Friday 14 11 08
Novavax, Inc. (Nasdaq: NVAX) announced that its strategy for treating avian flu through genetically-engineered virus-like particles (VLPs) was ranked as a Top Ten Innovation at Cleveland Clinic 6th Annual Medical Innovation Summit. Novavax, Inc. |
Thursday 13 11 08
WHO and CDC have stated that the predictive accuracy of their annual formulations for human influenza vaccines is "suboptimal" -- often correct less than 50% of the time, especially for seniors. Perhaps in part because we are not yet accurate in our predictions of upcoming influenza strains, approximately 36,000 people die each year of flu in the United States alone. |
Friday 07 11 08
A team of international researchers has written to the journal, The Lancet Infectious Diseases, calling for people to be vaccinated now against bird flu in order to mitigate the effects of global pandemic. Professor Karl Nicholson, Professor of Infectious Diseases at the University of Leicester and Consultant Physician at the Leicester Royal Infirmary is among those who has written the article. |
Tuesday 04 11 08
People should be vaccinated now against bird flu rather than waiting for a global pandemic to erupt, an international panel of experts - including a leading British influenza specialist - say in a new report. 1 The influenza researchers say the World Health Organisation (WHO) and national governments should give "urgent consideration" to the idea of priming people in advance of bird flu with a preparatory vaccination. |
Tuesday 21 10 08
A single vaccine could be used to protect chickens, cats and humans against deadly flu pandemics, according to an article published in the November issue of the Journal of General Virology. The vaccine protects birds and mammals against different flu strains and can even be given to birds while they are still in their eggs, allowing the mass vaccination of wild birds. |
Thursday 09 10 08
An international study led by University of Leicester researchers has determined that vaccination will be the best way to protect people in the event of the next influenza pandemic - but that each person would need two doses. In an article in the New England Journal of Medicine published on October 9, researchers from the University of Leicester and University Hospitals of Leicester report on a study carried out at the Leicester Royal Infirmary. |
Thursday 09 10 08
A vaccine available right now could help save lives in a future bird flu pandemic, UK scientists claim. |
Wednesday 08 10 08
People living in the Isle of Man who are eligible for free flu vaccinations are being urged to take up the offer. |
Friday 26 09 08
A new study shows that individuals immunized six years earlier with an MF59 adjuvanted H5N3 (clade 0) vaccine mounted a protective immune response seven days after a single immunization with an H5N1 (clade 1) vaccine containing the Novartis proprietary adjuvant MF59. The immune response was broadly cross reactive and covered all H5N1 clades known to date. These data were presented at the Third European Influenza Conference in Vilamoura, Portugal. |
Thursday 18 09 08
Results from two new clinical studies announced at the Third European Influenza Conference (ESWI) demonstrate that Prepandrix™, GlaxoSmithKline's (GSK) H5N1 adjuvanted pre-pandemic influenza vaccine, confers broad cross-clade immunity that is maintained when the second dose is given many months after the first dose, and even if the second dose is formulated from a different H5N1 strain. |